Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for reduced levels of BIC
Drug 1
Drug 2
Mechanism
Strong CYP3A4 induction
Clinical Effects
Potential decrease in antiretroviral efficacy
Management
Contraindicated. Use alternative agents.
Import ID
72
